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Chronic suppurative otitis media (CSOM) is a 
chronic infection of the middle ear cleft in which the 
tympanic membrane is not intact and otorrhoea is 
present.[1,2] The prevalence of CSOM in sub-Saharan 
Africa is between 0.4% and 4.2%, with >50% of cases 
occurring in children under the age of 10 years.[2-5] 
While the literature reports that the three organisms most commonly 
cultured in CSOM are Pseudomonas aeruginosa, Staphylococcus aureus 
and Klebsiella ssp,[6] a previous study at Universitas Academic Hospital 
(UAH) found the most common bacteria to be Proteus mirabilis 
(29.0%), followed by P. aeruginosa (23.7%).[7] In 2007, the incidence 
of tuberculosis in South Africa (SA) was estimated at 600 - 800 per 
100  000 population, and since has increased.[8] Studies from the 
early twentieth century found the prevalence of tuberculous CSOM 
in patients with CSOM to be between 1% and 5%.[9,10] However, a 
previous study at our hospital found Mycobacterium tuberculosis in 
only 1/114 (0.9%) ears with CSOM.[7]
CSOM may result in hearing loss, which can have a considerable 
negative effect on children’s speech, language and cognitive 
development and on school performance.[11,12] 
Objectives
To describe the otological, audiological and bacteriological findings 
in patients with CSOM and to assess the prevalence of tuberculous 
CSOM in children seen at the Ear, Nose and Throat (ENT) Clinic at 
UAH, Bloemfontein, Free State Province.
Methods
This was a prospective, descriptive study with a cross-sectional 
analytical component. Ethical approval for the study was obtained 
from the ethics committee of the Faculty of Health Sciences, 
University of the Free State.
We included all patients <13 years of age with CSOM, with 
otorrhoea for >4 weeks, examined at the ENT clinic at UAH between 
August 2009 and December 2010. Our exclusion criteria included: 
if the otorrhoea was due to otitis externa; if there was a stable, dry 
perforation on otoscopy; if there was otorrhoea with a grommet in situ; 
or if the parents did not give written consent to participate in the study. 
The external ear canal was cleaned using a microscope and 
handheld low-pressure suction and the tympanic membrane and 
middle ear mucosa were inspected. Two pus swabs were taken from 
each affected middle ear: 1 for routine microbiology, culture and 
fungal cultures and 1 for M. tuberculosis culture, taking care to limit 
contamination from the external ear canal. Details regarding the 
duration of symptoms, treatment received and response to treatment 
were recorded. Patients underwent voluntary HIV testing after 
appropriate counselling by HIV enzyme-linked immunosorbent 
assay (ELISA) (>18 months of age) or HIV polymerase chain 
reaction (PCR) (<18 months of age). Children who had previously 
been diagnosed with HIV were not re-tested. CD4+ T-cell counts 
were determined for HIV-positive children according to the age of 
the child.[13] The height and weight of all patients were plotted on 
standard World Health Organization (WHO) growth curves.
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Background. Chronic suppurative otitis media (CSOM) is a chronic infection of the middle ear cleft. In sub-Saharan Africa >50% of cases 
occur in children <10 years of age.
Objectives. To describe the otological, audiological and bacteriological findings in children with CSOM.
Methods. We conducted a prospective study at the Ear, Nose and Throat (ENT) Clinic at Universitas Academic Hospital between August 2009 
and December 2010. We included all children with CSOM over this period. Patients underwent ENT and paediatric examination, and were 
tested for HIV. Pus swabs were taken after an ear toilet for routine microbiology, fungal and Mycobacterium tuberculosis culture. We performed 
audiological testing after the otorrhoea had resolved.
Results. Eighty-six children (113 ears) were included, with a median age of 4.6 years (range 1 - 12 years). The mean duration of otorrhoea 
was 161.7 weeks (range 4 - 572 weeks). Nine patients (10.5%) presented with coalescent mastoiditis and/or intracranial complications of 
CSOM. Of the 153 organisms identified, Gram-negative bacteria were present in 93 (82.3%) ears, with 94.8% of these being sensitive to 
quinolones. Only 1 case of tuberculous otitis media was identified. HIV infection was present in 54.6% of patients tested. There was a 
hearing loss in 44 (66.7%) of the tested affected ears.
Conclusions. There was a long delay between the onset of symptoms and accessing ENT services. Most cases of CSOM were due to 
quinolone-sensitive Gram-negative aerobes. There was a high prevalence of cholesteatoma, hearing loss and other complications in children 
in this study.
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Audiological testing was performed once the otorrhoea had resolved. 
Air conduction thresholds were recorded by play or pure-tone 
audiometry, as appropriate for the age of the child, in a soundproof 
booth with a calibrated diagnostic audiometer (Madsen OB822 or 
Interacoustic AC33, respectively). When possible, bone conduction 
thresholds were measured. The pure tone average (PTA) was 
calculated as the average of the hearing thresholds at 500 Hz, 1 000 
Hz and 2 000 Hz.
Results are represented by frequencies and percentages. Groups 
were compared using t-tests, chi-squared or Fischer’s exact tests, as 
appropriate.
Results
Ninety-two children were enrolled in the study, but data collection 
was incomplete in 6, leaving 86 cases for analysis, comprising 45 
males (52.3%) and 41 females (47.7%). The median age was 4.6 years 
(range 1 - 12 years). Of the 113 ears evaluated, 59 (68.6%) patients 
had unilateral disease and 27 (31.4%) had bilateral disease with a 
slight right-sided predominance in 59 (52.2%) ears.
The mean duration of otorrhoea was 161.7 weeks (range 4 - 572 
weeks). Referrals came mainly from district hospital doctors (32.6%) 
and paediatricians in the public sector (31.4%), with relatively few 
referrals from the primary health sector (Table 1). There was a 
parental complaint of hearing loss in 48 (55.8%) children. Five (5.8%) 
patients had a history of prior adenoidectomy or adenotonsillectomy. 
Ventilation tubes had been inserted in 7/113 (6.2%) ears, but no 
patient had a ventilation tube in situ when entered into the study. No 
tympanoplasties had been performed but 1 patient had undergone 
tympanomastoidectomy at another hospital. The parents did not 
know the indication for this procedure. 
In the 3 months prior to enrolment, 55 (48.6%) ears in 42 (48.8%) 
patients had not received any treatment for CSOM while 58 (51.4%) 
ears had been treated. Eight (7.1%) ears were treated with topical acetic 
acid drops; 18 (15.9%) with topical quinolones; 26 (23.0%) with oral 
antibiotics; 8 (7.1%) with the combination of acetic acid drops and 
oral antibiotics and 4 (3.5%) with the combination of oral and topical 
antibiotics. Of the 16 ears treated with topical acetic acid drops, 2 
(12.5%) had improved with treatment. Ten (45.4%) of the ears treated 
with the topical antibiotics had responded to the initial treatment while 
11/38 (28.9%) ears treated with oral antibiotics initially responded. We 
were unable to document the class of antibiotic used since the children’s 
parents did not usually know which treatment was used.
Of the 113 tympanic membrane perforations, 25 (22.1%) were 
marginal perforations and 88 (77.9%) were central perforations. 
Ninety-six (85.0%) had a thickened appearance, with 63 (55.8%) 
displaying focal areas of granulation tissue. Three (2.7%) tympanic 
membranes had areas of myringosclerosis and 14 (12.4%) were 
inflamed. The middle ear mucosa was oedematous in 80 (70.8%) ears 
and appeared inflamed in 76 (67.3%). The affected middle ear spaces 
contained granulation tissue in 42 (37.2%) ears. Cholesteatoma was 
present in 23 (20.4%) of the 113 ears. None of the patients had a cleft 
palate or bifid uvula.
We cultured and identified 153 organisms (Table 2). Gram-
negative bacteria were present in 93 (82.3%) ears. P. mirabilis was 
the most common organism in 33 (29.2%) affected ears, followed by 
P. aeruginosa in 22 (19.5%) ears. No organisms were cultured in 6 
(5.3%) of the affected ears. Gram-negative bacteria were susceptible 
to ciprofloxacin in 94.8% of cases. M. tuberculosis was cultured from 
1 HIV-negative child, who also had coalescent mastoiditis and a 
subperiosteal abscess but did not have facial nerve palsy. 
The same bacteria were cultured from both ears in 15/27 (55.5%) 
children with bilateral perforations. In 9 (33.3%) patients, the same 
bacteria were found with 1 additional pathogen cultured in 1 of the 
ears, while in 3 (11.1%) cases the bacteria differed between the 2 ears. 
Thirty-five patients were known to be HIV-positive with 23 
(65.7%) receiving antiretroviral treatment. Forty-eight of the 51 
Table 1. Referring healthcare worker (N=86)
Referral n (%)
District hospital doctor 28 (32.6)
Public sector paediatrician 27 (31.4)
Primary healthcare doctor 15 (17.4)
Private general practitioner 11 (12.8)
Private paediatrician 1 (1.2)
Audiologist 3 (3.5)
Other 1 (1.2)
Table 2. Bacteria cultured (N=113)
Bacteria n (%)
Gram-negative aerobes
Proteus mirabilis 33 (29.2)
Pseudomonas aeruginosa 22 (19.5)
Haemophilus influenzae 22 (19.5)
Providencia stuartii 7 (6.2)
Escherichia coli 6 (5.3)
Klebsiella oxytoca 4 (3.5)
Klebsiella pneumonia 4 (3.5)
Citrobacter freundii 2 (1.8)
Proteus vulgaris 2 (1.8)
Acinetobacter baumannii 2 (1.8)
Burkholderia cepacia 2 (1.8)
Morganella morganii 2 (1.8)
Enterobacter cloacae 1 (0.9)
Gram-positive aerobes
Staphylococcus aureus 7 (6.2)
Streptococcus pyogenes 3 (2.7)
Enterococcus faecalis 2 (1.8)
Coagulase neg. Staphylococcus 2 (1.8)
Streptococcus group G 1 (0.9)
Streptococcus pneumonia 1 (0.9)
Streptococcus anginosus 1 (0.9)
Anaerobes
Bacteriodes thetaiotaomicron 6 (5.3)
Peptostreptococcus tetradius 5 (4.4)
Bacteroides ovatus 4 (3.5)
Fusobacterium necrophorum 3 (2.7)
Porphyromonas asaccharolytica 2 (1.8)
Peptostreptococcus anaerobius 1 (0.9)
Peptostreptococcus prevotii 1 (0.9)
Fusobacterium nucleatum 1 (0.9)
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patients whose HIV status was not known consented to HIV testing, 
with 10 (20.8%) of these patients testing positive. Thus, 45/83 (54.2%) 
patients were HIV-positive. CD4+ T-cell counts were measured in 
44/45 HIV-positive children: 22 were immunosuppressed, 4 mildly 
immunodeficient, 9 moderately immunodeficient and 9 severely 
immunodeficient. Other co-morbidities included anaemia in 39 
(45.3%) patients and malnutrition – 22/85 (25.9%) children being 
underweight and 29/82 (35.4%) showing stunting.
There was no significant difference in the bacteria cultured between 
HIV-negative and HIV-positive patients or between the anaemic and 
non-anaemic patients (p>0.05). Among HIV-positive patients, there 
was no significant difference between the immunosuppressed and 
non-immunosuppressed patients. However, P. mirabilis was found 
significantly more frequently in patients who were underweight 
(40.9% v. 17.5%; p=0.0256).
Nine patients (10.5%) had complications of CSOM with 6 patients 
having >1 complication. Complications occurred in 6/21 (28.6%) 
patients (6/23 ears) that had a cholesteatoma (Table 3). Mastoiditis 
and subperiosteal abscess formation were significantly more common 
in ears with cholesteatoma than those without (p<0.0001). 
Because of difficulty with follow-up and audiology staffing 
shortages, audiological testing could only be performed in 46 (53.5%) 
patients (66 affected ears) (Table 4). Forty-four (66.7%) of the ears 
tested had a hearing loss, as defined by a PTA >25 decibels hearing 
level (dB HL). Bone conduction thresholds could only be determined 
for 11 affected ears as a result of the young age of most of the children. 
Because of the small number, these results are not reported.
There was a parental complaint of hearing loss in 48 (72.7%) of those 
ears that underwent audiological testing. The median PTA was 41.7 dB 
HL in ears where there was a complaint of hearing loss compared 
with 25.0 dB HL in ears where there was no such complaint (p=0.05). 
There was no association between the type of perforation (central v. 
marginal) or the presence of cholesteatoma and a PTA >25  dB HL 
(p=0.5068 and p=0.4262, respectively). There was no correlation 
between the duration of otorrhoea and audiometric thresholds 
(Spearman correlation coefficient ≤0.2 for all tested frequencies and 
for the PTA). The audiometric thresholds did not differ significantly 
between the HIV-positive and HIV-negative patients (p>0.05), nor 
did they differ significantly between the immunosuppressed and non-
immunosuppressed HIV-positive patients (p>0.05).
Discussion
The mean duration of otorrhoea in patients included in the study was 
161 weeks (>3 years), which may be due to various factors: (i) lack of 
access to primary health services; (ii) lack of, or delayed, referral from 
primary healthcare to ENT services; (iii) tolerance of the otorrhoea by 
parents and healthcare workers who are often unaware of the serious 
nature of CSOM; and (iv) limited availability of specialist ENT services 
in the province. Uncomplicated CSOM is painless and not physically 
debilitating, thus patients and caregivers may feel no urgency to seek 
prompt treatment,[12] emphasised by the 32% of children that were 
referred from paediatric clinics, most likely being examined primarily 
for other reasons. 
There is a lack of consensus regarding the transition from acute otitis 
media with perforation of the tympanic membrane to CSOM – the 
WHO considers CSOM to be indicated if otorrhoea is present for ≥2 
weeks,[2] while others consider ≥6 weeks.[1] For our inclusion criteria, we 
chose 4 weeks as the duration of otorrhoea to include as many patients 
with CSOM as possible, but exclude patients with acute otitis media.
There was an almost equal distribution of male and female 
patients in our study, in contrast to other studies that found a male 
predominance.[4,5,14-16] The predominance of unilateral disease in 
children with CSOM has previously been noted.[3,12,16-19]
Most children who had been treated prior to referral did not respond 
to the treatment given or relapsed, which was the reason for referral. 
Treatment failure may be due to failure to combine ear toilet with 
medical treatment, the use of ineffective treatment or the result of 
re-infection related to poor hygienic conditions.[2,3] Removal of pus and 
debris improves the quality of the examination and the efficacy of topical 
agents in eradicating infections in the middle ear and mastoid.[6] Indeed, 
ear toilet on its own may be as efficacious as ear toilet combined with 
ototopical or parenteral treatment,[19] although Smith et al.[20] did not find 
this to be the case. We did not document if ear toilet had previously been 
performed in our patients.
Table 3. Ear complications (N=113)
n (%)
Complication
Cholesteatoma
(N=23)
No cholesteatoma 
(N=90)
Mastoiditis 6 (26.1) 1 (1.1)
Meningitis 1 (4.3) 2 (2.2)
Subperiosteal abscess 6 (26.1) 0 (0)
Intracranial abscess 1 (4.3) 0 (0)
Facial nerve palsy 1 (4.3) 0 (0)
Table 4. Pure tone audiometry results
n (%)
Threshold (dB HL) 
250 Hz
(N=50)
500 Hz 
(N=65)
1 000 Hz
(N=66)
2 000 Hz 
(N=65)
4 000 Hz 
(N=55)
Average 
500 - 2 000 Hz
(N=65)
Median 45 45 35 35 35 38.3
≤25 13 (26) 19 (29.2) 21 (31.6) 23 (35.4) 14 (25.5) 21 (32.3)
26 - 40 10 (20) 13 (20) 15 (22.7) 21 (32.3) 20 (36.4) 13 (20)
41 - 55 9 (18) 12 (18.6) 11 (16.7) 9 (13.9) 6 (10.9) 10 (15.4)
56 -70 8 (16) 11 (16.9) 11 (16.7) 5 (7.7) 9 (16.4) 13 (20)
71 - 90 5 (10) 5 (7.7) 2 (3) 0 (0) 0 (0) 2 (3)
≥90 5 (10) 5 (7.7) 6 (9) 7 (10.8) 6 (10.9) 6 (9.2)
dB HL = decibels hearing level.
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Only 2/16 ears treated with acetic acid drops improved. This lack of 
effectiveness of acetic acid has been documented in a recent SA study.[21] 
CSOM is a condition occurring mainly in patients of low 
socioeconomic status,[2,12,18] who may not have access to clean water. 
Exposure of the auditory canals to contaminated water has been 
identified as a risk factor for CSOM.[19]
P. mirabilis and P. aeruginosa were identified as the most prevalent 
pathogens, in keeping with previously reported data.[7] There was 
a low prevalence of S. aureus, in contrast to other studies in the 
literature that found S. aureus to be one of the most prevalent 
bacteria in CSOM.[4,5,14-16,21] An Angolan study in which 64% of 
children with CSOM were HIV-positive also found Proteus spp. to 
be the most commonly cultured bacteria.[18] The authors speculated 
that this was a result of the high rate of HIV infection predisposing 
patients to infections by low-virulence bacteria. However, we did not 
find a significant difference in the bacteria cultured between the HIV-
positive and HIV-negative patients, nor was there a significant difference 
between the HIV-positive patients who were immunosuppressed 
and those who were not immunosuppressed. Notably, P. mirabilis 
was cultured significantly more commonly in children who were 
malnourished. Despite the high prevalence of HIV infection in our 
patients and the high prevalence of tuberculosis in SA, only 1 case of 
tuberculous CSOM was detected, in an HIV-negative patient. 
In 44.4% of patients with bilateral disease there was a difference 
in the bacteriology between the 2 ears, indicating that separate pus 
swabs need to be taken in cases in which both ears are infected. 
Despite the fact that quinolones as ear drops have been used to treat 
CSOM for ±15 years, 94.8% of Gram-negative bacteria identified 
were sensitive to these agents. The use of ototopical quinolones has 
not been found to lead to the development of resistant pathogens 
since the antibiotic concentration achieved is thousands of times 
higher than the minimum inhibitory concentration required to cause 
bacterial death.[22] As oral quinolones are not used in public sector 
clinics to treat children, there is less selective pressure on bacterial 
populations and thus less resistance to the quinolones in children.
Cholesteatoma was present in 23 (20.4%) ears, with mastoiditis 
and intracranial complications occurring more often in ears with 
a cholesteatoma. As cholesteatoma is a disease requiring surgical 
intervention, delayed referral for CSOM can delay the diagnosis of 
cholesteatoma and subsequent management, which can lead to a 
higher incidence of serious and life-threatening complications.
When audiological testing could be performed, there was a 
tendency towards statistical significance in the worse PTA in ears 
where there was the symptom of hearing loss compared with ears 
where there was no parental complaint of hearing loss. A Kenyan 
study found that 69.7% of parents of children with hearing loss 
were aware of the hearing loss, with parental awareness in all cases 
of children with hearing loss due to CSOM.[23] Thus, parental 
complaints of suspected hearing loss should always be heeded.
Of the patients tested, 44 (67.7%) had a hearing loss, which was severe 
or profound in 21 (31.3%) patients. In contrast, Adoga et al.[15] in Nigeria 
found hearing loss to be present in all their patients, which was mild in 
most cases; while Couzos et al.,[22] in a study on Australian Aborigines 
with CSOM, found that 54% of their patients >3 years of age had an 
average air conduction hearing threshold >26 dB, but that the hearing 
loss was mild or moderate in all cases. In a Nigerian study on CSOM 
in school children, Olatoke et al.[12] found hearing loss to be present in 
65.4% of patients; 38.5% of patients had mild hearing loss and 26.9% 
moderate hearing loss with the presence of hearing loss being associated 
with significantly worse academic school performance. 
Hearing loss is present in 33 - 38% of HIV-infected children and 
may be conductive or sensorineural.[24,25] Although we did not find 
a significant difference in the hearing thresholds between the HIV-
positive and HIV-negative patients, it is possible that HIV infection 
created a sensorineural hearing loss that contributed to the more 
severe hearing loss in our patients.
Conclusions
There was a long delay between the onset of symptoms and accessing 
specialist ENT services. During this period the majority of children received 
no or ineffective treatment for their CSOM. Gram-negative aerobes were 
the most commonly identified bacteria, with most being sensitive to topical 
quinolones. Oral antibiotic therapy was usually ineffective. Despite the 
high prevalence of HIV infection, anaemia and malnutrition, tuberculous 
otitis media was rare. There was a high prevalence of cholesteatoma, 
mastoiditis, intracranial complications and hearing loss in the children 
included in this study. The majority of serious complications occurred 
in patients with cholesteatoma. Since the treatment for cholesteatoma is 
surgical, prompt referral and surgical management can lead to a decrease 
in serious and life-threatening complications.
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